MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202441036594 A) filed by Sri Ramachandra Institute Of Higher Education And Research, Chennai, Tamil Nadu, on May 8, 2024, for 'a process of combo nanoformulation for the delivery of combo drugs (decursin and enzalutamide) elastin nanogels for prostate cancer therapy and product thereof.'

Inventor(s) include Vinoth Kumar Lakshmanan; Gulzar Ahmed Rather; Satish Srinivas Kondaveeti; and Kumaresan Natarajan.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "The present invention discloses a process of preparation of decursin and enzalutamide drug inco...